Health News: [cancer]

CytRx’s INNO-206 in Combination Therapy Induces Complete Remissions in Aggressively Growing Ovarian Cancer Tumor Model Business Wire Mon, 01 Aug 2011 05:39 AM PDT LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical company specializing in oncology, today announced the achievement of complete remissions in aggressively growing in vivo ovarian cancer tumors treated with a combination of low doses of CytRx’s tumor-targeted albumin-binding doxorubicin conjugate INNO-206 and the commonly prescribed cancer treatment doxorubicin ... UK & World News: UK women face greater cancer risk icNewcastle - Sunday Sun Mon, 01 Aug 2011 05:36 AM PDT British women are 17% more likely to develop cancer than those in Europe - and obesity and alcohol could be partly to blame, experts say. Using math to fight cancer EurekAlert! Mon, 01 Aug 2011 05:34 AM PDT ( University of Miami ) Researchers from the University of Miami and the University of Heidelberg in Germany have developed a mathematical model to understand and predict the progress of a tumor, from its early stages to metastasis, in hopes of creating highly personalized treatment strategies for patients who have cancer. The findings are published in Nature's new online journal Scientific ... Doctors aim to stop pancreatic cancer before it forms The Salinas Californian Mon, 01 Aug 2011 05:34 AM PDT BALTIMORE â€" Seeing a chance to stop one of the most deadly kinds of cancer before it forms, doctors at hospitals around the nation are focusing on the common pancreatic cyst. College football: St. Johns graduate Paksi playing for his life Eaton Rapids Community News Mon, 01 Aug 2011 05:32 AM PDT Former St. Johns football player Julian Paksi (60), now a senior at Albion College, learned in January that he has a rare form of cancer diagnosed in only a few hundred people each year in the U.S. He needs a liver transplant liver but isn't yet on a waiting list because he plans to play football this fall. Green: Consequences of a Meltdown: A Footnote New York Times Mon, 01 Aug 2011 05:25 AM PDT A study reflects scientific uncertainty about the relationship between the size of a radiation dose and the probability of its causing cancer in the long term. Sir Bobby Robson cancer fund tops £3.5m The Journal Mon, 01 Aug 2011 05:25 AM PDT THE cancer foundation set up by Sir Bobby Robson has reached a huge milestone on the eve of the second anniversary of his death. UK women face greater cancer risk Independent Mon, 01 Aug 2011 05:24 AM PDT British women are 17% more likely to develop cancer than those in Europe - and obesity and alcohol could be partly to blame, experts say. Gov. Cuomo to Sign Bill Banning Kids' Products with Flame Retardant WENY-TV Mon, 01 Aug 2011 05:22 AM PDT ALBANY (WENY) â€" Governor Andrew Cuomo is set to sign a bill banning the sale of childrens' products treated with a flame retardant chemical. The chemical commonly known as Tris has been linked to cancer in test animals. Alnylam Completes ALN-VSP Phase I Trial in Patients with Liver Cancer Business Wire Mon, 01 Aug 2011 05:19 AM PDT CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it has completed its Phase I study with ALN-VSP, a systemically delivered RNAi therapeutic for the treatment of advanced solid tumors with liver involvement. “We are very pleased with the results of our ALN-VSP Phase I trial that demonstrate safety and ...

See more health stories that match my keyword Visit Yahoo! Health

You received this email because you subscribed to Yahoo! Alerts. Use this link to unsubscribe from this alert. To change your communications preferences for other Yahoo! business lines, please visit your Marketing Preferences. To learn more about Yahoo!'s use of personal information, including the use of web beacons in HTML-based email, please read our Privacy Policy. Yahoo! is located at 701 First Avenue, Sunnyvale, CA 94089.